F. Venturella, G. Cancellieri, M. Giammanco, A. Almerico, Igor Daniele Aleo, A. Liga, F. Mortillaro, Irene Mistretta
{"title":"Immuno-oncological treatment of Non-Small-Cell Lung Cancer (NSCLC) in advanced stage with Nivolumab","authors":"F. Venturella, G. Cancellieri, M. Giammanco, A. Almerico, Igor Daniele Aleo, A. Liga, F. Mortillaro, Irene Mistretta","doi":"10.4081/jbr.2023.11027","DOIUrl":null,"url":null,"abstract":"In recent years, significant scientific progress has been made in the therapy of non-small cell lung cancer (NSCLC), which has made possible a better knowledge of this pathology and above all the realization of new personalized therapies. The main therapeutic revolution in advanced NSCLC is immuno-oncology, a new therapeutic strategy that aims to awaken the immune system to fight cancer cells.","PeriodicalId":9116,"journal":{"name":"Bollettino della Societa italiana di biologia sperimentale","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bollettino della Societa italiana di biologia sperimentale","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4081/jbr.2023.11027","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
In recent years, significant scientific progress has been made in the therapy of non-small cell lung cancer (NSCLC), which has made possible a better knowledge of this pathology and above all the realization of new personalized therapies. The main therapeutic revolution in advanced NSCLC is immuno-oncology, a new therapeutic strategy that aims to awaken the immune system to fight cancer cells.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
